LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Clinical trial NCT02705196 · COMPLETED

Trial details

NCT number: NCT02705196
Sponsor: Lokon Pharma AB
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2016-11-01
Primary completion: 2025-11-15
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.